Therapeutic Device Reduces Disability Following Stroke
|
By HospiMedica International staff writers Posted on 22 Feb 2021 |
|
Image: Low intensity electromagnetic fields can assist recovery from stroke (Photo courtesy of BrainQ)
Artificial intelligence (AI) powered therapy generates electromagnetic fields that enhance recovery and reduce disability caused by ischemic stroke.
The BrainQ (Jerusalem, Israel) BQ System is a cloud-connected wearable device that delivers extremely low frequency low intensity electromagnetic fields (ELF-EMF), tailored to the individual patient. By measuring several electrophysiology measures, such as electroencephalography (EEG), electromyography (EMG), and magnetoencephalography (MEG), which characterize the neural oscillatory activity, the device can deliver the neuromodulatory ELF-EMF therapy at specific frequencies to influence these oscillations and aid neurorecovery.
The BQ System extends the window of opportunity for stroke treatment from several hours during the acute phase to days and even weeks in the sub-acute phase following stroke. The effect of ELF-EMF on recovery from neurological conditions include evidences of changes in calcium signaling, which is known to influence and mediate nearly all cellular processes; proliferation, as well as differentiation, of multiple cell types (including neurogenesis of neural stem cells); peripheral nerve regeneration; effects on polar molecules, likely responsible for the development of the neural projections; and changes in plasticity-related growth factor levels in humans.
“Stroke is a debilitating condition with limited recovery options, creating a huge unmet need in the United States. Covid-19 has only made things worse by limiting patients' access to treatment facilities,” said Yotam Drechsler, CEO and co-founder of BrainQ. “We are on the verge of a new era where AI- based precision medicine will be used to treat neurodisorders, which do not have a sufficient solution to date.”
Neuroplasticity describes the ability of neural networks in the brain to change through growth and reorganization. These changes range from individual neuron pathways making new connections, to systematic adjustments like cortical remapping. Neuroplasticity was once thought to exist only during childhood, but research has shown that activity-dependent plasticity, which can manifest even in adulthood, can have significant implications for recovery from brain damage.
Related Links:
BrainQ
The BrainQ (Jerusalem, Israel) BQ System is a cloud-connected wearable device that delivers extremely low frequency low intensity electromagnetic fields (ELF-EMF), tailored to the individual patient. By measuring several electrophysiology measures, such as electroencephalography (EEG), electromyography (EMG), and magnetoencephalography (MEG), which characterize the neural oscillatory activity, the device can deliver the neuromodulatory ELF-EMF therapy at specific frequencies to influence these oscillations and aid neurorecovery.
The BQ System extends the window of opportunity for stroke treatment from several hours during the acute phase to days and even weeks in the sub-acute phase following stroke. The effect of ELF-EMF on recovery from neurological conditions include evidences of changes in calcium signaling, which is known to influence and mediate nearly all cellular processes; proliferation, as well as differentiation, of multiple cell types (including neurogenesis of neural stem cells); peripheral nerve regeneration; effects on polar molecules, likely responsible for the development of the neural projections; and changes in plasticity-related growth factor levels in humans.
“Stroke is a debilitating condition with limited recovery options, creating a huge unmet need in the United States. Covid-19 has only made things worse by limiting patients' access to treatment facilities,” said Yotam Drechsler, CEO and co-founder of BrainQ. “We are on the verge of a new era where AI- based precision medicine will be used to treat neurodisorders, which do not have a sufficient solution to date.”
Neuroplasticity describes the ability of neural networks in the brain to change through growth and reorganization. These changes range from individual neuron pathways making new connections, to systematic adjustments like cortical remapping. Neuroplasticity was once thought to exist only during childhood, but research has shown that activity-dependent plasticity, which can manifest even in adulthood, can have significant implications for recovery from brain damage.
Related Links:
BrainQ
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Vessel Sealing Instrument
ERGOseal
New
Monitor/Defibrillator
Zenix
Latest Patient Care News
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
